Substance related schizophrenia and psychosis and mood affective disorders outline and case analysis

Things that may be involved include: Someone may inherit a tendency to develop schizoaffective disorder from their parents. Schizoaffective disorder usually begins in the late teen years or early adulthood, often between ages 16 and It seems to happen slightly more often in women than in men.

Substance related schizophrenia and psychosis and mood affective disorders outline and case analysis

Homicide — In some rare situations, a person who is depressed or manic may become homicidal; homicidal behavior is another indication for inpatient treatment Loss of work time Interpersonal problems Prolonged hospital stays Regular assessment for suicide risk is mandatory in any patient with depression or mania.

Other risk factors for suicide include agitation, psychosis, past suicide attempts, a family history of suicide, other psychiatric comorbidity, and recent psychiatric admission. Previous Inpatient and Outpatient Care Inpatient care If the substance-induced mood disorder SIMD symptoms are severe or cause significant risk of harm to the patient or others, inpatient psychiatric care needs to be considered.

In addition, any evidence of impaired reality or psychosis should lower the threshold for considering inpatient care. When patients are paranoid or having hallucinations, they are much less likely to be able to communicate the extent of their symptoms.

If there is uncertainty about the diagnosis, a prompt evaluation by the local emergency mental health system or a local emergency department is indicated. Specific indications for inpatient care include the following: If an abnormal mood persists, institute standard treatment for depression or mania, and consider etiologies other than substance-induced mood disorders.

Prevention Prophylactic treatment of SIMD can be recommended on a case-by-case basis when there is significant risk associated with a recommended drug eg, interferon [IFN]-alpha or steroid-induced depression, or steroid-induced mania. The following needs to be considered when prophylactic treatment is recommended [ 24 ]: Several case reports and open-label trials reported successful prophylactic use of lithium, valproic acid, chlorpromazine, olanzapine, and lamotrigine for steroid-induced mania.

Cases of suicide have been reported. If a patient reports a history of mood symptoms upon exposure to a medication, avoid that medication in the future if at all possible.

For patients with a history of mood symptoms who require steroid treatment, prophylactic treatment with an antipsychotic agent concomitantly with the steroid treatment can prevent or decrease steroid-induced manic symptoms.

Prognosis If a drug causes the mood disorder, removal of the offending agent usually results in total recovery to predrug functioning.

The resolution of symptoms can take time, but it is usually less than 4 weeks. Careful monitoring is recommended until the mood symptoms resolve. No evidence suggests that the morbidity and mortality from drug-induced depression are different from those from any other depressive illness.

No mechanisms of action have been proposed to explain these correlations. Estimates of lost wages and productivity due to mood disorders are estimated at millions of dollars annually.

Suicide risk in children, adolescents, and young adults Inthe US Food and Drug Administration FDAfollowing the lead of the Medicines and Healthcare products Regulatory Agency MHRA a drug-monitoring agency in the United Kingdomissued a warning about increased risk for suicidal behavior in children and adolescents using antidepressants.

This warning has been updated several times. Decreased suicidal thinking and behavior in adults older than 65 years have been linked to antidepressants in the first 2 months of use. Since this black box warning was added, the adolescent suicide rate has increased for the first time since the early s.

Two randomized, controlled studies showed that the risk of attempted and completed suicide attempts is highest before treatment and decreases in a linear fashion after treatment either antidepressant medication or psychotherapy.

No evidence has been found that suggests antidepressant use is associated with an increased risk of completed suicide in children, adolescents, or adults. No mechanism of action has been implicated linking suicide to antidepressant use.

However, the recommendation for close monitoring of patients who have recently been started on treatment for depression is quite sound and is likely to decrease the risk for completed suicide.

Previous References American Psychiatric Association. American Psychiatric Association; Interferon-induced depression in chronic hepatitis C: Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C.

Substance-Induced Mood Disorder: Overview, Substances Linked to Depression or Mania, Etiology

J Interferon Cytokine Res. Patten SB, Barbui C. Psychiatric adverse effects of corticosteroids. Lanoxin digoxin tablets [package insert]. Research Triangle Park, NC: Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med.

Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Briefing document for the July 10, advisory committee meeting to discuss antiepileptic drugs AEDs and suicidality [memorandum].

Viadur leuprolide acetate implants [package insert]. Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment. GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization-embryo transfer cycles.Dorothy Wood Substance-related, Schizophrenia and Psychosis, and Mood/Affective Disorders Outline and Case Analysis Definition s Substance related Schizophrenia and Psychosis Mood/Affect Disorders DSM-IV TR Disorders • Substance abuse • Substance dependence • Schizophrenia 1.

For example, an etiological relationship between epilepsy and psychosis is supported by recent CNV studies 85 and could in part be explained by ion channel dysfunction. 86 Another important example is the relationship between mood disorders and cardiovascular disease including sudden death.

Substance related schizophrenia and psychosis and mood affective disorders outline and case analysis

87 In part, this could be related to ion channel. Catatonic Disorder Due to Another Medical Condition. Clinicians use this classification when there is evidence from the history, physical examination, or laboratory findings that the disturbance is the direct pathophysiological consequence of another medical condition.

We have compiled the definitions of over different terms used in brain and spinal cord injury treatment and schwenkreis.comtanding the terms used in the first step in becoming an effective part of the treatment team. Psychosis is an abnormal condition of the mind that results in difficulties determining what is real and what is not.

Symptoms may include false beliefs (delusions) and seeing or hearing things that others do not see or hear (hallucinations). Other symptoms may include incoherent speech and behavior that is inappropriate for the situation. There may also be sleep problems, social withdrawal.

Substance related schizophrenia and psychosis and mood affective disorders outline and case analysis

Substance-related, Schizophrenia and Psychosis, and Mood/Affective Disorders Outline and Case Analysis Project description Resources: DSM IV-TR (located on ERR page), Abnormal Psychology, and Case Studies in Abnormal Behavior Create a detailed outline in which you address the following items: • Define the major DSM IV-TR categories of substance-related, psychosis, and mood/affective disorders.

Psychopharmacology: A Practical Clinician's Guide by John Preston, Psy.D., ABPP